A51
Engineering the logic layer of biology
A51 is building in human regeneration by unlocking a new layer of biology where RNA becomes a controllable interface.
Founders
Marina Katava
CEO
Marina holds a PhD in Computational Biophysics from Sorbonne University in Paris, France. She is a Lindau Nobel and a Marie Curie Fellow, and previously worked with pharma companies at McKinsey.
Viktor Zahoransky
CTO
Viktor has a PhD in Biophysics from ESPCI Paris, the best bioengineering institution in Europe. He is a Marie Curie Fellow and developed technology now being licensed to the biotech industry.